Follow us on:
Dedication / Services
To provide 50000 services and products to global scientific research units every year

Labetuzumab

DESCRIPTION CATALOG # SIZE PRICE
Anti-Human CEACAM5 Therapeutic Antibody (CEA-Cide) TAB-033 1mg Please Inquiry
Product Detail
Cat
TAB-033
Product Overview
Mab to CEA. Recombinant monoclonal antibody to CEA. Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer.
Target
CEACAM5
Type
IgG
Immunogen
Purified CEA emulsified in complete Freund`s Adjuvant.
Species Reactivity
Human
Expression Host
CHO
Applications
Suitable for use in ELISA, IP, FC, FuncS, Neut, IF, ICC and most other immunological methods.
CAS
219649-07-7
Trade name
cea-cide
Specificity
Tested positive against native human antigen.
Protein Construction
Immunoglobulin G,anti-(human carcinoembryonic antigen) (human-mouse monoclonal huMN-14 g-chain), disulfide withhuman-mouse monoclonal hMN-14 k-chain, dimer
Predicted N terminal
H chain: EVAQLVES; L chain: DIQLTQS
Purity
>95.0% as determined by analysis by SDS-PAGE.
Size
1mg
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Background
Antigen Description
Cell surface glycoprotein that plays a role in cell adhesion and in intracellular signaling. Receptor for E.coli Dr adhesins.
Gene ID
1048
Synonyms
CEACAM5; carcinoembryonic antigen-related cell adhesion molecule 5; CEA; CD66e; meconium antigen 100; DKFZp781M2392;
Download Datasheet:

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

Online Inquiry
Please input "biolabs"(case insensitive) as verification code.
Loading...
Contact Us

USA
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email: 

Europe
Tel: 44-207-097-1828


© 2007 - 2017 Creative-Biolabs All Rights Reserved